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ABSTRACT Ion-solvent interactions play a very important role in the studies of stoichiometry, structure, and stability of
complexes of cations with natural and synthetic ionophores. These compounds are extremely useful in study of the
interaction of neutral salts with macromolecules and the mechanism of cation transport across biological membranes.
Knowledge of the ionophore solvation properties enables one to choose a suitable solvent for complexation studies and to
obtain detailed information on the solvent effect. We would like to present in this paper a very simple method of
estimating the solvation properties of ionophores. We treat the ligand as an assembly of individual noninteracting
binding sites. The solvation properties of solvents can be used to represent the solvation sites in natural and synthetic
ligands. The solvation properties are represented by the Gutmann donor number (DN) of the model solvent. We can
define the solvation ability of a ligand binding site to be "donor number of binding site" (DNbjndjngsjit), which in turn can
be represented by the DN of the appropriate model solvent. The average DN of the ligand (DNave.age) is defined as [(7i
(DNbindjing,jt)iJ/n, where n is the number of the ligand binding sites. Comparison of the DNaverage with the DNSOivent,
together with the knowledge of the composition of the system, characterizes remarkably well the solvation properties of
the ligand. This model explains (a) the stoichiometry of many alkali and alkaline earth cation complexes with natural
and synthetic ligands in aprotic organic solvents, (b) the transport of alkali and alkaline earth cations across lipid
bilayers, and (c) how polypeptides and proteins interact with neutral salts in solutions.
INTRODUCTION
Since the discovery of the specific potassium ion-binding
capabilities of the antibiotic valinomycin (1), there have
been many studies of the complexing abilities of naturally
occurring and synthetic peptides (2-4). The preponder-
ance of these studies have focused upon the relationship of
the structure of the ionophore to its ion-binding ability; the
crucial nature of the solvent in many of these reactions has
often been neglected. Because we wish to understand better
the contribution that the solvent makes to many funda-
mental properties of such complexes, we have undertaken a
study of the stoichiometry of two ligands in three different
solvents. Our hope is that it will be possible to rationalize
our results, and the results of others, using a relatively
simple model of ion solvation. The approach that we take is
an extension of the method of Eisenmann and co-workers
(5, 6), who showed that the solvation of ions by ion carriers
can be approximated by the solvation of the same ions by
appropriate solvents. We characterize the solvent by its
Guttman donor number (7-9) and devise a method of
assigning a Guttmann donor number to the ionophore. The
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two factors that then determine the possible stoichiome-
tries of the complexes are the relative magnitudes of the
mean donor number of the ligand and of the solvent and
the ratio of the concentration of the cation to the ligand.
The two ligands that we have chosen are the crown ether
2,3-benzo- 1,4,7,10,1 3-pentaoxacyclopentadeca-2-
ene (benzo-15-crown-5) (Fig. la) and the linear hexapep-
tide Boc-(Gly-L-Pro)3OBz (Fig. lb). Benzo-15-crown-5 is
a typical crown ether forming well-defined complexes with
many alkali and alkaline earth cations (10). In these
complexes the cation is located in the center of the main
macrocyclic ring, more or less in the plane defined by the
oxygen atoms; the forces responsible for the formation of
this complex are primarily ion-dipole in nature. The ability
of peptides to bind metal ions has been well documented,
particularly with respect to divalent cations (4-6). We
have investigated the stoichiometry of the binding of
benzo-l 5-crown-S to sodium ion(s) in nitromethane and in
diethyl ether and of Boc(Gly-L-Pro)3OBz to magnesium in
acetonitrile using 'H NMR as a probe of the extent of the
complexation reaction.
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FIGURE I (a) Benzo-1 5-crown-5; (b) Boc-(Gly-L-Pro)3OBz.
[NocI04V[B-15-c-5]
FIGURE 2 Downfield increments of chemical shifts of 'H signals of
Benzo-15-crown-5 VS. [NaCI04J/[Benzo-15-crown-5J ratio. (a) 0.02M
solutions of Benzo-15-crown-5 in nitromethane. (b) 0.02M solutions of
Benzo-15-crown-5 in Diethylether. Numbers at the right indicate signal
assignment (cf. Fig. Ia). Full lines correspond to the computed points.
EXPERIMENTAL PROCEDURES
Boc(Gly-L-Pro)3OBz was prepared according to the procedure given by
Deber and Blout (11). Benzo-1 5-crown-5 was prepared following the
method of Pedersen (10).
All solvents (nitromethane, acetonitrile, and diethyl ether) were
obtained from Merck at 99.9% deuteration (Merck Chemical Div.,
Merck & Co., Inc., Rahway, NJ) and were dried for 48 h over molecular
sieve 4A. NaCJO4 (Fisher Analar, Fisher Scientific Co., Pittsburgh, PA.)
and Mg(SCN)2 (Fisher Analar) were dried under vacuum 10-4mmHg at
80°C for 48 h. Solutions were prepared under nitrogen.
'H NMR spectra were recorded at 270 MHz on a spectrometer
(Bruker Instruments, Inc., Billerica, MA, model WH-270) operating in
the Fourier transform mode, using 5-mm sample tubes. The deuterium
signals of the solvents served as internal locks and TMS (tetra methyl
silane) as an internal reference. All experiments were conducted at 270C.
NMR measurements of the 'H chemical shifts of the complexes were
performed on solutions prepared by mixing 0.02 M solutions of the
ligands with 0.02 M ligand and 0.1 M salt solutions in the same solvent.
The procedure described by Reuben and co-workers (12,13), for the
conditions of fast exchange of the ligand was used for the data analysis.
RESULTS
Complexes with Benzo- 1 5-crown-5
Pronounced changes in the chemical shifts of the various
protons were observed as a function of the ratio of salt
concentration to ligand concentrations in both nitro-
methane and diethyl ether. These results are presented
graphically in Fig. 2.
To fit the experimental chemical shifts in nitromethane
with appropriate equilibrium expressions, it was necessary
to hypothesize the existence of three distinct reactions:
Kl
Na+ + benzo-1 5-crown-5 (benzo-15-crown-5)Na+
K2
(benzo- 1 5-crown-5)Na + + benzo- 1 5-crown-5-
(benzo- 1 5-crown-5)2 Na+
K,12(benzo-15-crown-5)Na+ + Na+ -
(benzo-1 5-crown-5)(Na+ )2-
In diethyl ether, however, the third expression was found
not to be required; in other words, there is no reason to
postulate the existence of a "cation-sandwich" complex.
Values of the intrinsic chemical shifts of the complexes
and the values of the corresponding equilibrium constants
TABLE I
STABILITY CONSTANTS OF THE NAC104
(BENZO-15-CROWN-5) COMPLEXES
Solvent DN K2 K, K
(M-') (M-') (M-')
Nitromethane 2.7 75 + 15 >10 15 ± 3
Diethylether 19.2 10 ± 4 285 ± 18 none
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TABLE II
THE INTRINSIC CHEMICAL SHIFTS OF THE BENZO-15-CROWN-5 PROTONS (PPM RELATIVE TO TMS)
Solvent System Proton H, H2 HA,
Nitromethane C* 3.66 4.01 6.67
C2 NaC 104 3.70 ± 0.02 4.06 ± 0.02 6.68 ± 0.01
CNaC104 3.82 ± 0.01 4.14 ± 0.01 6.70 ± 0.01
C(NaCl04)2 3.85 ± 0.01 4.17 ± 0.01 6.70 ± 0.01
Diethylether C* 3.67 4.03 6.69
C2 NaCl04 3.70 ± 0.03 4.07 ± 0.03 6.71 ± 0.01
CNaCl04 3.77 ± 0.02 4.12 ± 0.02 6.72 ± 0.01
C - Benzo-15-Crown-5
*Directly measured values.
K,, K2, and K112, were calculated by iteration from the
experimentally observed chemical shifts. The equilibrium
constants are given in Table I, and the intrinsic chemical
shifts given in Table II.
Complexes with Boc-(Gly-L-Pro)3OBz
The changes in the observed chemical shift of the amide
protons as a function of the ratio of Mg(SCN)2 concentra-
tion to peptide concentration in acetonitrile are shown in
Fig. 3. Now, to adequately fit this curve, it was necessary to
[MlCcO4k4PIst*de]
FIGURE 3 Downfield increment of chemical shifts of 'H glycil amide
signal vs. [Mg (SCN)21/[Boc (Gly-L-Pro)3OBzJ ratio, 2 x 10-2M
solutions of Boc-(Gly-L-Pro)3 OBz in acetonitrile. Full lines correspond to
the computed values.
TABLE III
STABILITY CONSTANTS OF THE
[MG(SCN)2J[BOC(GLY-L-PRO)3 OBz] COMPLEXES IN
ACETONITRILE.
K, K2 K,/2 K,,3
(M-') (M-A') (A-) (A-')
(4±0.2)x103 250±30 78± 13 5± 1
TABLE IV
THE INTRINSIC CHEMICAL SHIFTS OF THE
BOC-(GLY-L-PRO)3 OBz AMIDE N-H PROTONS (PPM
RELATIVE TO TMS) IN ACETONITRILE
N-H glycines protons
System
HI H2 H3
C* 7.01 7.09 7.22
C2Mg(SCN)2 7.17 ± 0.02 7.17 ± 0.02 7.17 ± 0.02
C Mg(SCN)2 7.42 ± 0.02 7.42 ± 0.02 7.42 ± 0.02
C [Mg(SCN)2]2 7.63 ± 0.03 7.63 ± 0.03 7.63 ± 0.03
C [Mg(SCN)2J3 7.71 + 0.03 7.71 + 0.03 7.71 + 0.03
C - Boc-(Gly-L-Pro)3OBz
*Directly measured values.
8.0 7.0
8; ppm
FIGURE 4 The 6.5-8.0 ppm region of 270 MHz 'H NMR spectra of: (a)
2 x 10- M Boc (Gly-L-Pro)3 OBz in acetonitrile; (b) solution of 2 x 10-2
M Boc (Gly-L-Pro)3 OBz and 10-2M Mg(SCN)2 in acetonitrile; (c)
solution of 2 x I0-2M Boc (Gly-L-Pro)3 OBz and 2 x 10-2M Mg(SCN)2
in acetonitrile; (d) solution of 2 x 10-2M Boc (Gly-L-Pro)3 OBz and 4 x
10-2 M Mg(SCN)2 in acetonitrile.
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utilize four equilibrium expressions:
K,
Mg2+ + peptide_ peptide-Mg2+
K2
peptide-Mg2+ + peptide peptide2-Mg2+
Mg++M2+ K1/2 M2peptide-Mg2+ g - peptide-(Mg2+)
peptide-(Mg2 )2 + Mg2+ peptide_(Mg2+)3.
The observed chemical shifts were not reproduced ade-
quately when only the first three equilibrium expressions
were used; consequently, we postulated the existence of the
"tri-magnesium" complex. The calculated equlibrium con-
stants are given in Table III and intrinsic chemical shifts in
Table IV.
The amide region of the 270 MHz 'H NMR spectra of
the free peptide and mixtures with Mg(SCN)2 with rela-
tive ratios of [Mg2+]/[peptide] of 0.5, 1.0, and 2.0 in
acetonitrile are shown in Fig. 4.
In the free peptide there are three distinct chemical
shifts for the N-H protons at 7.01, 7.09, and 7.29 ppm;
however, the complexed peptide has only one peak, which
shifts downfield with increasing magnesium salt concen-
tration. The appearance of only one peak may well indicate
that the peptide in the complex is more highly symmetric
than is the free peptide. The phenyl ring protons of the
benzoate group (b = 7.36 ppm) do not shift upon com-
plexation, suggesting that the benzoate group is unper-
turbed by the magnesium.
DISCUSSION
Our results give strong evidence for the existence of
complexes of the form (peptide-Mg+2), (peptide2-
Mg+2), [peptide-(Mg+2)2] and [peptide-(Mg+2)3]. In
the crown ether studies, stoichiometries of (crown-Na+),
(crown2-Na+), and [crown-(Na+)2] were observed. The
particular stoichiometry observed in each case is a function
both of the solvent and the ratio of cation to ligand present
in solution. We propose a simple, qualitative model of the
solvation properties of the ligands, solvents, and cations,
which predicts remarkably well the stoichiometries of the
complex species that are formed.
Current theories of ion solvation are based upon models
in which the interactions between the ion and solvent
dipoles and multipoles as well as the structural changes
imposed on the solvent molecules by the ion are taken into
account (14). Our model "averages" these complex effects
into an effective interaction based on the relative Lewis
acidities of the solvent and metal ions. Solvents are, of
course, either Lewis acids or bases; because most metal
ions are Lewis acids, interactions will take place between
metal ions and base solvent molecules leading to solvated
metal cations.
Gutmann (7-9) has quantified Lewis acidity and
basicity by doing calormetric measurements on the inter-
actions of a number of oxygen and nitrogen containing
solvents using antimony chloride as a reference acceptor in
dichloroethane: D + SbCl5 D*SbCl5. He defined the
quantity -AH(D. SbCl5) in kcal/mol to be the donor
number (DN) of the solvent D. Donor numbers and
dielectric constants (e) of various solvents are given in
Table V (9).
The donor number is a molecular property of the solvent
that is easily determined experimentally. It expresses the
total interaction of the donor with an acceptor molecule,
including such contributions as the dipole-dipole or ion-
dipole interactions as well as the binding effect caused by
the availability of a free electron pair. To some extent even
steric properties of the solvent molecules are contained in
the donor number. The solvation properties of a given
solvent can therefore be reasonably well characterized by
TABLE v
DONOR NUMBER (DN) AND DIELECTRIC CONSTANTS
(X) OF CERTAIN SOLVENTS*
Solvent DN
1,2-Dichloroethane - 10.1
Sulphuryl chloride 0.1 10.0
Thionyl chloride 0.4 9.2
Acetyl chloride 0.7 15.8
Benzoyl chloride 2.3 23.0
Nitromethane 2.7 35.9
Nitrobenzene 4.4 34.8
Acetic Anhydride 10.5 20.7
Benzonitrile 11.9 25.2
Selenium oxychloride 12.2 46.0
Acetonitrile 14.1 38.0
Sulpholane 14.8 42.0
Propanediol- 1,2-carbonate 15.1 69.0
Benzyl cyanide 15.1 18.4
Ethylene sulphite 15.3 41.0
iso-Butyronitrile 15.4 20.4
Propionitrile 16.1 27.7
Ethylene carbonate 16.4 89.1
Phenylphosphonic difluoride 16.4 27.9
Methylacetate 16.5 6.7
n-Butyronitrile 16.6 20.3
Acetone 17.0 20.7
Ethyl acetate 17.1 6.0
Water 18.0 81.0
Phenylphosphonic dichloride 18.5 26.0
Diethylether 19.2 4.3
Tetrahydrofurane 20.0 7.6
Diphenylphosphinic chloride 22.4
Trimethyl phosphate 23.0 20.6
Tributyl phosphate 23.7 6.8
Dimethylformamide 26.6 36.1
N,N-Dimethylacetamide 27.8 38.9
Dimethyl sulphoxide 29.8 45.0
N,N-Diethylformamide 30.9
N,N-Diethylacetamide 32.2
Pyridine 33.1 12.3
Hexamethylphosphoramide 38.8 30.0
*Data from reference 4.
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its donor number. This fact was demonstrated by Popov
and co-workers in studies of ion solvation by organic
solvents (15, 16).
Although varying widely both structurally and confor-
mationally, the natural and synthetic ionophores that bind
alkali and alkaline earth cations have a common feature:
the solvation spheres of their bound cations are filled by
amide, ether, ester, or other polar groups just as they are in
solvation by any organic molecules containing these
groups. Formation of these complexes can thus be likened
to transfer of the cations from a weaker to a stronger
solvating medium. Indeed, the complexes are structurally
similar in many respects to the crystallosolvates that alkali
metal (particularly sodium and lithium) salts form with a
number of ketones and amides (4, 17), (see Fig. 5).
If the cooperative effects of ligand binding sites are
ignored, one can treat the ligand as an assembly of
individual binding sites. The solvation properties of com-
monly used solvents can then be used as models for the
solvation properties of binding sites in natural and syn-
thetic ionophores. Diethyl ether can be used to represent
the etheral oxygens in crown ethers and polyethylene
glycols; and tetrahydrofurane can be used to represent the
etheral oxygens in natural antibiotics such as nonactin,
monensin, nigericin, or dianemycin. N,N-dimethylacet-
amide and N,N,-dimethylformamide are models of amido
groups in natural antibiotics such as valinomycin, enniatin-
B, antamanide, and synthetic ionophores such as cyclopep-
tides and amido ethers. The solvation properties of ethyl
acetate are a model for those of ester groups in natural
antibiotics such as valinomycin and nonactin. The justifi-
cation for this model is found in the work of Eisenman and
co-workers (5, 6) (see Fig. 6). We can now define the
solvation ability of a ligand binding site to be the donor
number of binding site (DNbinding site), and we assume that
DNbinding site can be represented by the DN of the model
solvent, i.e.,
DNethereal oxygen of Crown ether = DNdimethylether
DNamido group of ionophore = DNdimethylacetamide
DNester group of ionophore = DNethylacetate-
One can calculate the average DN of the ligand
(DNaverage):
nI
DNaverage - | E (DNbindingsite)i n
where n is the number of the binding sites in the ligand.
DNaverage represents the ability to estimate the solvation
power of a ligand when it acts as an assembly of individual
binding sites, in competition with common solvents. It is
assumed that the DNaverage is the lowest limit of the
solvation ability of a ligand; natural and synthetic ligands
possess higher solvation ability than that presented by
DNaverage because of cooperative and macrocylic effects.
FIGURE 5 Sodium ion surrounded in the crystallosolvate
[HCON(CH3)216 Nal. , C; (0, N; O, 0.
Comparison of the DNaverage with DN solvent can explain
many results of complexation of alkali and alkaline earth
cations with natural and synthetic ligands in different
solvents.
It is noteworthy that natural antibiotics (18-22), cyclic
peptides (23-30), and related ligands (31-33) form sand-
wich complexes in solution in addition to ligand-cation
(1:1) complexes. These include the following (with cation-
ligand stoichiometries indicated in parentheses): ligand
sandwich ( 1:2), and cation sandwich (2:1). From a variety
of experimental studies (18-33), it appears that when the
solvation number of the cation is equal to the number of
ligand binding sites, the cation-ligand (1:1) complex is
the most stable species regardless of the DNaverage-DNsolvent
relationship. We suggest that the 1:1 complex is formed
first; the [cation] / [ligand] ratio then determines the sand-
wich complex(es) that may be formed. This can be
described by the following three equations:
ligand + cation ligand cation (1:1) (1)
ligand cation + ligand
Iigand2 * cation (ligand sandwich) (1:2) (2)
ligand * cation + cation
-ligand * cation2 (cation-sandwich) (2:1). (3)
The suggested stoichiometry of complexes for the different
DNaverage-DNsolvent relationships is summarized in Table
VI.
We hypothesize that the formation of cation-sandwich
H3c Qo)H33C CyHH
~~a
H3CQ&H3
H3CCH3
H2C CH
12CeH2
0 + 0 b
H2C 0 H
H2C CH2
FIGURE 6 Ion solvation by methyl ether compared to "ion solvation" by
a polyether. This figure illustrates schematically that the replacement of
solvent molecules about an ion is analogous to the spatial array of the
same ligands about the ion in an ion carrier complex. (a) methyl ether; (b)
polyether.
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TABLE VI
PREDICTED STOICHIOMETRY OF COMPLEXES IN THE DIFFERENT DNAVERAGE-DNSOLVENT RELATIONS
Relation DNAVERAGE- DNsvent Concentration ratio . Stoichiometry
number relation (cation)/(ligand) Equation of complexes (predicted)
31 (1 ) cation ligand (1:1)(3) cation sandwich (2: 1)
I DNaverage > DNsolvent
(1) cation ligand (1:1)
(2) ligand sandwich (1:2)
> 1( 1 ) cation ligand ( 1:1 )
11 DNaverage DNsolvent
( I ) cation ligand (1:1)
(2) ligand sandwich (1:2)
III DNaverage < DNsolvent (1) cation ligand (1:1)
(2:1) complexes is possible only when DNaverage is greater
than DNsolvent. The fact that the solvation interaction with
solvent molecules is weaker than the ligand interaction
enables the ligand cation complex to react with a second
cation to form the cation-sandwich complex if [cation]/
[ligand] >I (see Eqs. 1, 3). Similarly, in the-concentration
region [cation/[ligand) < 1, we expect the formation of
ligand-cation (1:1) and ligand-sandwich (1:2) complexes
(see Eqs. 1,2), because the cations are maximally solvated
by the ligand binding sites.
When DNaverage - DNsolven, there are several distinct
stoichiometrics possible. If [cation] / [ligand] > 1, we
expect only the ligand-cation (1:1) complex; but if [ca-
tion] /[ligand] < 1, we expect both the ligand-cation (1:1)
and the ligand-sandwich (1:2) complexes. The cation-
sandwich (2:1) complex is not expected to form with an
excess of cations because the solvent more effectively binds
the excess cations than does the already formed ligand-
cation ( 1:1 ) complex.
When DNaverage < DNsolvent, we expect the formation of
the ligand-cation ( 1:1 ) complex only. In these solvents, the
donicity of which is larger than that of the ligand binding
sites, the complexing ability of the ligand is rather limited
and apparently only the ligand-cation (1:1) complex may
be formed if indeed any is formed at all.
The approximate DNaverage value of peptides is 27 and
the DN of acetonitrile is 14.1. Thus peptides in acetonitrile
obey the criterion that DNaverage > DNsolvent. In this case we
would expect to have cation-sandwich and ligand-sandwich
complexes of linear and cyclo-peptides with alkali and
alkaline earth cations. Our experimental data confirm this
model (see Figs. 5, 6 and Tables III, IV). According to
these results we suggest that the complexation of Boc(Gly-
L-Pro)3 OBz with Mg (SCN)2 in acetonitrile can be
described by the following mechanism (see Fig. 7).
In the first step, one molecule of peptide with six binding
sites (amide carbonyl oxygens) solvates one magnesium ion
(solvation number = 6) to form a stable (1:1) complex.
When the ratio [cation] / [ligand] < 1, the 1:1 complex
reacts further with the excess of peptide to form the
ligand-sandwich complex; and when [cation] / [ligand] > 1,
the 1:1 complex reacts further with an excess of salt to
form the cation-sandwich complex. The cation-sandwich
complex may react further with an excess of salt to form
the tri-magnesium complex.
The values of [cation]/[binding sites] range from '/A2 in
the ligand-sandwich complex to 1/2 in the tri-magnesium
complex. There are, thus, a greater number of ion-dipole
interactions of the peptide with the salt in the tri-
magnesium complex. The strength of these interactions
depends on the donor number of the binding site (polar
group), as well as the size, charge, and polarizability of the
ion.
It may be suggested that polypeptides and proteins
interact with neutral salts in aqueous solutions by the same
mechanism. Polar groups (binding sites) are often found in
the interior of macromolecules (e.g., the peptide bonds
1II + 0 v
)0
0
0<
0
'An
FIGURE 7 Suggested mechanism for the complexation of Mg(SCN)2
by Boc(Gly-L-Pro)3OBz in acetonitrile. 0 - Mg(SCN)2;
TI' = Boc(Gly-L-Pro)3OBz.
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connecting nonpolar, buried protein side chains), and so
interactions of such groups (binding sites) with alkali and
alkaline earth cations that tend to alter the free-energy
difference between folded and unfolded forms of the
macromolecule can certainly alter the stability of macro-
molecular conformations.
The complexation studies of benzo- 1 5-crown-5 with
NaClO4 in nitro-methane (DNaverage > DNsolvent) and in
diethyl ether, (DNaVeage = DNsolvent) together with experi-
mental data of other studies of ionophores complexed with
alkali and alkaline earth cations analyzed according to
Table VI, support the above model (18-33).
Cyclic-peptides in acetonitrile meet the criterion that
DNaverage > DNsolvent. This is consistent with the formation
of cation-sandwich and ligand-sandwich complexes of cyc-
lic peptides with alkali and alkaline earth cations and
ammonium salts in this particular solvent (23-30).
Additional support for this model comes from complexa-
tion studies of LiCIO4 with a linear amido-ether ligand in
nitro-methane and pyridine done by Olsher et al. (31). The
approximate DNaverage of the amido ether ligand is 23.5 and
DN of nitramethane is 2.7. In this case DNaverage> DNsolvent
again; the cations are maximally solvated by the ligand
binding sites rather than by solvent molecules. Thus we
find the cation-sandwich (2:1) complex in solutions with
excess salt. The DN of pyridine is 33.1. The amido ether in
pyridine therefore meets the criterion that DNaverage <
DNsolvent leading to the formation of only the cation-ligand
(1:1) complex in this solvent.
Complexation studies of the natural antibiotics valino-
mycin (18-20, 22), enniatins (20, 21) and antamanide
(18-20) also support this model. Eisenman and Margalit
(32) have studied ion permeation in lipid bilayers by the
amido-ether ligand (31). They found that the amido ether
can act in bilayer membranes as a pure equillibrium
domain carrier of monovalent cations forming ligand-
cation (1:1) and ligand-sandwich (1:2) membrane-
permeating complexes. If we assume that the lipid bilayer
is a solvent with a very low D.N. value, then the stoichiom-
etry of the complexes can be explained by the suggested
model. DNaverage(amido ether) >> DNsolvent(lipid bilayer); thus we find
the ligand-cation (1:1) and ligand-sandwich (1:2) com-
plexes (see Eqs, 1, 2) in the membrane, which is a solution
with excess ligand.
CONCLUSIONS
This simple model, although not accounting for the contri-
butions of cooperative and macrocyclic effects to the
complexation ability of the natural and synthetic iono-
phores and ignoring possible entropic contributions (a)
reflects the important contribution of the solvation proper-
ties of the individual binding sites of ionophores, (b) does
correctly predict the stoichiometry of many alkali and
alkaline earth cation complexes with natural and synthetic
ionophores in many aprotic organic solvents, and (c) does
explain the transport of alkali and alkaline earth cations
across lipid bilayers and how polypeptides and proteins
interact with neutral salts in solutions.
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